BioPharmX Reports First Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
BioPharmX (BPMX) Reports Q1 Loss of $0.08/Share, Explores Funding Alternatives
June 13, 2017 4:10 PM EDTBioPharmX (NYSE: BPMX) reported Q1 EPS of ($0.08), versus ($0.17) reported last year.
The company expects the phase 3 program to begin later this year and is exploring a variety of funding alternatives, including both dilutive and non-dilutive financing options and strategic partnerships.
For earnings... More



